Variables | Non-pacemaker group (n = 48) | Pacemaker group (n = 20) | P value |
---|---|---|---|
Age (years) | 74.59 ± 7.805 | 74.20 ± 9.18 | 0.902 |
Sex (male) | 28 (58.3%) | 7 (35%) | 0.111 |
BMI (kg/m2) | 21.03 ± 2.57 | 21.13 ± 3.048 | 0.925 |
STS score | 7.68 ± 1.25 | 8.40 ± 1.96 | 0.306 |
Past medical history | |||
Hypertension | 34 (70.8%) | 11 (55.0%) | 0.264 |
Coronary heart disease | 10 (20.8%) | 7 (35%) | 0.235 |
Diabetes | 4(8.3%) | 6 (30%) | 0.054 |
Laboratory data | |||
Leukocyte count (109/L) | 5.24 ± 1.63 | 5.18 ± 0.88 | 0.919 |
Red blood cell count (1012/L) | 3.93 ± 0.50 | 3.84 ± 0.56 | 0.636 |
Hemoglobin level (g/L) | 117.91 ± 15.83 | 116.10 ± 16.93 | 0.771 |
Platelet count (109/L) | 158.09 ± 58.55 | 156.60 ± 51.58 | 0.945 |
Total cholesterol level (mmol/L) | 3.75 ± 0.95 | 3.74 ± 1.33 | 0.985 |
Low-density cholesterol level (mmol/L) | 2.03 ± 0.81 | 2.10 ± 0.84 | 0.843 |
Creatinine level (µmol/L) | 83.64 ± 30.27 | 95.76 ± 47.18 | 0.387 |
Fasting glucose level (mmol/L) | 4.68 ± 0.429 | 5.18 ± 0.72 | 0.064 |
High-sensitivity troponin level (ng/mL) | 0.011 (0.009,0.025) | 0.009 (0.004,0.183) | 0.131 |
CKMB level (U/L) | 15.82 ± 6.80 | 11.60 ± 5.66 | 0.098 |
BNP level (pg/mL) | 329.00 (144.00,848.75) | 89.50 (63.00,251.00) | 0.040 |
Electrocardiography findings | |||
Preoperative QRS width (ms) | 102.05 ± 20.14 | 114.20 ± 25.36 | 0.155 |
Preoperative cRBBB or first-degree AV block | 2 (4.2%) | 10 (50%) | < 0.001 |
Echocardiography | |||
LA (mm) | 44.32 ± 4.99 | 40.30 ± 8.53 | 0.103 |
LV (mm) | 56.55 ± 8.37 | 56.90 ± 8.77 | 0.914 |
IVS (mm) | 9.89 ± 1.88 | 9.9 ± 1.91 | 0.985 |
LVEF (%) | 52.95 ± 9.69 | 52.90 ± 9.53 | 0.988 |
Mitral curtain length (mm) | 4.86 ± 1.25 | 5.00 ± 0.94 | 0.761 |
LVOT type (non-tubular) | 14 (29.2%) | 16 (80.0%) | < 0.001 |
CT data | |||
Mean diameter of AA (mm) | 24.66 ± 2.23 | 24.16 ± 3.14 | 0.607 |
Mean diameter of LVOT (mm) | 24.96 ± 3.19 | 24.20 ± 4.01 | 0.566 |
Mean diameter of STJ (mm) | 35.32 ± 3.12 | 33.99 ± 4.45 | 0.336 |
Angle of the aortic root (°) | 55.50 ± 10.25 | 59.90 ± 8.25 | 0.243 |
Mean diameter of AAO (mm) | 43.17 ± 3.04 | 40.23 ± 5.56 | 0.061 |
AA calcification | 6 (12.5%) | 3 (15.0%) | 1 |
LVOT calcification | 2 (4.2%) | 2 (10%) | 0.575 |
Valve device and TAVR intervention procedures date | |||
Valve device type (mm) | 28.66 ± 1.78 | 28.32 ± 2.28 | 0.586 |
Valve implantation depth (mm) | 2.44 (0.00, 5.06) | 4.73 (2.46, 6.29) | 0.118 |
Other | |||
Largest diameter of the upper corolla of the valve device / diameter of AAO | 0.99 ± 0.067 | 1.08 ± 0.14 | 0.090 |
Diameter of the inferior edge of valve device/diameter of aortic annular | 1.24 ± 0.07 | 1.25 ± 0.09 | 0.672 |
Diameter of the inferior edge of valve device/Mean diameter of LVOT | 1.23 ± 0.11 | 1.26 ± 0.14 | 0.553 |
Mean diameter of LVOT/Mean diameter of aortic annular | 1.01 ± 0.07 | 1.00 ± 0.06 | 0.643 |